| Term 
 | Definition 
 
        | CH 15 Diuretics Carbonic Anhydrase Inhibitor   
| CA inhibitors block HCO3- reabsorption in PCT and cause diuresis; hyperchloremic metabolic acidosis reduces body pH; ↓ intraocular pressure | Metabolic acidosis, renal stones, ↑ K+ secretion, hyperammonemia in cirrhotics Altered taste | Glaucoma, urinary alkalinization (enhance secretion of weak acids), mountain sickness, edema with alkalosis |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Loop Diuretics   
| Inhibit Na+/K+/2Cl- transporter in the TAL reducing reabsorption of NaCl; diminishes lumen positive potential created by K+ back diffusion which drives Mg+2 and Ca+2 reabsorption | Ototoxicity, hypokalemia, hypocalcemia, hypovolemia, hyperuricemia (precipitate gout), hypomagnesemia, allergic reactions to sulfonamides | Pulmonary edema, peripheral edema, hypertension, acute hypercalcemia or hyperkalemia, acute renal failure, anion overdose |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Loop Diuretics   
| Not a sulfonamide but has typical loop activity and some uricosuric action | Ototoxicity, hypokalemia, hypocalcemia |   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Potassium-Sparing Diuretics   
| Anatagonist of aldosterone, weak antagonism of androgen receptors;  | Hyperkalemia, gynecomastia (spironolactone, not eplerenone) | Aldosteronism from any cause, hypokalemia due to other diuretics, post MI |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Potassium-Sparing Diuretics   
| Direct inhibitor of epithelial Na+ channels in CCT in collecting tubules; since K+ secretion is coupled with Na+ entry in CCT these agents are also K+ sparing | Hyperkalemia metabolic acidosis | Hypokalemia from other diuretics, reduces lithium-induced polyuria |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Potassium-Sparing Diuretics   
| Like spironolactone, more selective for aldosterone (mineralocorticoid) receptors | Less active on androgen and progesterone receptors = ↓ adverse effects than spironolactone |   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Potassium-Sparing Diuretics   
| Like amiloride, Direct inhibitor of epithelial Na+ channels in CCT, but metabolized in liver = less potent, more toxic | hyperkalemia |   |  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics Osmotic Diuretic   
| Filtered by glomerulus but not reabsorbed; ↓ brain volume, ↓intraocular pressure | Nausea, vomiting, headache | Renal failure due to increased solute load (eg. rhabdomyolysis), glaucoma, increased intracranial pressure |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 15 Diuretics ADH antagonists   
| Antagonist at V1a and V2 ADH receptors, reduces water reabsorption, ↑ plasma Na+ | Hypernatremia and nephrogenic diabetes insipidus | Syndrome of Inappropriate ADH Secretion (SADH), hyponatremia due to ADH excess |    |  | 
        |  |